zy1501 catalog jul2015 v2 - zydus pharmaceuticals...(updated as of august 2015) summer 2015 1 ndc...

23
New Launches Etomidate Injection, USP Isosorbide Mononitrate ER Tablet Morphine Sulfate ER Tablet Pyridostigmine Bromide Tablet, USP (updated as of August 2015) SUMMER 2015

Upload: others

Post on 09-Jul-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

New LaunchesEtomidate Injection, USPIsosorbide Mononitrate ER TabletMorphine Sulfate ER TabletPyridostigmine Bromide Tablet, USP

(updated as of August 2015)

SUMMER 2015

Page 2: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

1 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Acetazolamide Extended-Release CapsulesAB-Rated to Diamox® Sequels

68382-0261-01 500mg 100 24 Capsule; Orange Opaque/White Opaque; EP/107

Acyclovir TabletsAB-Rated to Zovirax® Tablets

68382-0791-01 400mg 100 24 Round; White to Off-White; 791

68382-0791-05 400mg 500 12 Round; White to Off-White; 791

68382-0792-01 800mg 100 24 Oval; White to Off-White; 792

68382-0792-05 800mg 500 12 Oval; White to Off-White; 792

Amiodarone HCl TabletsAB-Rated to Cordarone® Tablets

68382-0227-14 200mg 60 24 Round; White to Off-White; Bisect, ZE 65

68382-0227-05 200mg 500 12 Round; White to Off-White; Bisect, ZE 65

Amlodipine Besylate TabletsAB-Rated to Norvasc® Tablets

68382-0121-16 2.5mg 90 24 Round; White to Off-White; Z/7

68382-0121-05 2.5mg 500 12 Round; White to Off-White; Z/7

68382-0122-16 5mg 90 24 Round; White to Off-White; Z3

68382-0122-05 5mg 500 12 Round; White to Off-White; Z3

68382-0123-16 10mg 90 24 Round; White to Off-White; Z5

68382-0123-05 10mg 500 12 Round; White to Off-White; Z5

Anastrozole TabletsAB-Rated to Arimidex® Tablets

68382-0209-06 1mg 30 24 Round; White; A7

68382-0209-10 1mg 1000 12 Round; White; A7

Atenolol Tablets, USPAB-Rated to Tenormin® Tablets

68382-0022-01 25mg 100 24 Round; White to Off-White; Z/65

68382-0022-10 25mg 1000 12 Round; White to Off-White; Z/65

68382-0023-01 50mg 100 24 Round; White to Off-White; Bisect, Z 66

68382-0023-10 50mg 1000 12 Round; White to Off-White; Bisect, Z 66

68382-0024-01 100mg 100 24 Round; White to Off-White; Z 67

68382-0024-10 100mg 1000 12 Round; White to Off-White; Z 67

Page 3: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

2 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Azathioprine Tablets, USPAB-Rated to Imuran® Tablets

68382-0003-01 50mg 100 24 Round; Yellow, Bisect; ZC 59

68382-0003-05 50mg 500 12 Round; Yellow, Bisect; ZC 59

Benzonatate Capsules, USPAA-Rated to Tessalon® Perles

68382-0247-01 100mg 100 24 Round; Light Yellow; Z

68382-0247-05 100mg 500 12 Round; Light Yellow; Z

68382-0248-01 200mg 100 24 Round; Light Yellow; β

Bromocriptine Mesylate Capsules, USPAB-Rated to Parlodel® Capsules

68382-0110-06 5mg 30 24 Capsule; Tan/White; ZA-17/5 mg

68382-0110-01 5mg 100 24 Capsule; Tan/White; ZA-17/5 mg

Bupropion Extended-Release TabletsAB-Rated to Wellbutrin XL® Extended-Release Tablets

68382-0354-06 300mg 30 24 Round; Creamy-white to Pale-Yellow; 354

68382-0354-05 300mg 500 12 Round; Creamy-white to Pale-Yellow; 354

Buspirone HCl Tablets, USPAB-Rated to BuSpar® Tablets

68382-0180-01 5mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 36

68382-0180-05 5mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 36

68382-0181-01 10mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 37

68382-0181-05 10mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 37

68382-0182-01 15mg 100 24 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 5 5 5

68382-0182-05 15mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 5 5 5

68382-0183-14 30mg 60 24 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 10 10 10

68382-0183-05 30mg 500 12 Capsule-shaped; White to Off-White; Bisect, ZE 38/Trisect, 10 10 10

Carvedilol TabletsAB-Rated to Coreg® Tablets

68382-0092-01 3.125mg 100 24 Round; White to Off-White; Z/1

68382-0092-05 3.125mg 500 12 Round; White to Off-White; Z/1

68382-0093-01 6.25mg 100 24 Round; White to Off-White; ZC40

68382-0093-05 6.25mg 500 12 Round; White to Off-White; ZC40

Carvedilol Tablets continued on next page

Page 4: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

3 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Carvedilol Tablets (continued)AB-Rated to Coreg® Tablets

68382-0094-01 12.5mg 100 24 Round; White to Off-White; ZC41

68382-0094-05 12.5mg 500 12 Round; White to Off-White; ZC41

68382-0095-01 25mg 100 24 Round; White to Off-White; ZC42

68382-0095-05 25mg 500 12 Round; White to Off-White; ZC42

Clarithromycin for Oral Suspension, USPSame as Biaxin® Granules for Oral Suspension

68382-0764-05 125mg/5mL 50 mL 48 White to off-white granules; Fruit Punch fl avor

68382-0764-06 125mg/5mL 100 mL 48 White to off-white granules; Fruit Punch fl avor

68382-0765-05 250mg/5mL 50 mL 48 White to off-white granules; Fruit Punch fl avor

68382-0765-06 250mg/5mL 100 mL 48 White to off-white granules; Fruit Punch fl avor

Clarithromycin Tablets, USPSame as Biaxin® Filmtab

68382-0761-14 250mg 60 48 Oval; Yellow; “a” logo KT

68382-0762-14 500mg 60 48 Oval; Yellow; “a” logo/KL

Divalproex Sodium Capsules (Sprinkle)AB-Rated to Depakote® Sprinkle Capsules

68382-0106-01 125mg 100 24 Capsule; Blue/White; ZA66/125mg

68382-0106-10 125mg 1000 12 Capsule; Blue/White; ZA66/125mg

Divalproex Sodium Delayed-Release Tablets, USPAB-Rated to Depakote® Delayed-Release Tablets

68382-0031-01 125mg 100 24 Oval; White to Off-White; ZA08

68382-0031-05 125mg 500 12 Oval; White to Off-White; ZA08

68382-0032-01 250mg 100 24 Oval; White to Off-White; ZA07

68382-0032-05 250mg 500 12 Oval; White to Off-White; ZA07

68382-0033-01 500mg 100 24 Oval; White to Off-White; ZA06

68382-0033-05 500mg 500 12 Oval; White to Off-White; ZA06

Page 5: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

4 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Divalproex Sodium Extended-Release TabletsSame as Depakote® Extended-Release Tablets

68382-0314-01 250mg 100 24 Ovaloid; White; “a” logo HF

68382-0314-05 250mg 500 12 Ovaloid; White; “a” logo HF

68382-0315-01 500mg 100 24 Ovaloid; Gray; “a” logo HC

68382-0315-05 500mg 500 12 Ovaloid; Gray; “a” logo HC

Donepezil HCl Orally Disintegrating TabletsAB-Rated to Aricept ODT®

68382-0346-06 5mg 30 24 Round; White to Off-White; ZF14

68382-0347-06 10mg 30 24 Round; White to Off-White; ZF15

Duloxetine HCl Delayed-Release CapsulesAB-Rated to Cymbalta®

68382-0385-14 20mg 60 24 Capsule; Green/White; 241/20 mg

68382-0386-06 30mg 30 24 Capsule; Blue/Green; 242/30 mg

68382-0387-06 60mg 30 24 Capsule; Blue/White; 243/60 mg

Etodolac Extended-Release TabletsAB-Rated to Lodine XL® Extended-Release Tablet

68382-0271-14 400mg 60 24 Oval; Orange; 271

68382-0271-01 400mg 100 24 Oval; Orange; 271

68382-0272-14 500mg 60 24 Oval; Grey; 272

68382-0272-01 500mg 100 24 Oval; Grey; 272

68382-0273-14 600mg 60 24 Oval; Blue; 273

68382-0273-01 600mg 100 24 Oval; Blue; 273

Etomidate Injection, USPAB-Rated to Amidate® Injection

68382-0545-07 2mg/mL 10 mL 24 SD vial, 10 vials per carton

68382-0545-08 2mg/mL 20 mL 12 SD vial, 10 vials per carton

Page 6: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

5 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Famotidine for Oral Suspension, USPAB-Rated to Pepcid® for Oral Suspension

68382-0444-05 40mg/5mL 50 mL 24 White to Off-White; Cherry-Mint fl avor

Fenofi brate TabletsSame as TriCor® Tablets

68382-0228-16 48mg 90 24 Oval; Yellow; “a” logo/FI

68382-0230-16 145mg 90 24 Oval; White; “a” logo/FO

Fenofi bric Acid Delayed-Release CapsulesSame as Trilipix® Delayed-Release Capsules

68382-0077-16 45mg 90 24 Capsule; Reddish-brown/Yellow; “a” logo/45

68382-0078-16 135mg 90 24 Capsule; Blue/Yellow; “a” logo/135

Gabapentin TabletsAB-Rated to Neurontin® Tablets

68382-0204-01 600mg 100 24 Oval; White to Off-White; ZE72 bisect/bisect

68382-0204-05 600mg 500 12 Oval; White to Off-White; ZE72 bisect/bisect

68382-0205-01 800mg 100 24 Oval; White to Off-White; ZE71 bisect/bisect

68382-0205-05 800mg 500 12 Oval; White to Off-White; ZE71 bisect/bisect

Galantamine HBr Tablets, USPAB-Rated to Razadyne® Tablets

68382-0177-14 4mg 60 24 Round; Light Pink; 77/Z

68382-0178-14 8mg 60 24 Round; Off-White; 78/Z

68382-0179-14 12mg 60 24 Round; Off-White; 79/Z

Haloperidol Tablets, USPAB-Rated to Haloperidol Tablets, USP

68382-0079-01 5mg 100 24 Capsule; Green; Partial Bisect, ZC 07

68382-0079-10 5mg 1000 12 Capsule; Green; Partial Bisect, ZC 07

68382-0080-01 10mg 100 24 Capsule; Light Green; Partial Bisect, ZC 08

68382-0081-01 20mg 100 24 Capsule; Coral; Bisect, ZC 09

Page 7: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

6 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Hydroxychloroquine Sulfate Tablets, USPAB-Rated to Plaquenil® Tablets

68382-0096-01 200mg 100 24 Capsule; White to Off-White; ZC38

68382-0096-05 200mg 500 12 Capsule; White to Off-White; ZC38

Isosorbide Mononitrate Extended-Release TabletsAB-Rated to Imdur® Tablets

68382-0650-01 30mg 100 24 Oval; Reddish Pink; "N" bisect "30"/ Bisect

68382-0651-01 60mg 100 24 Oval;Yellow;"N" bisect "60"/ Bisect

68382-0652-01 120mg 100 24 Oval; White, N120

Lamotrigine Chewable Dispersible TabletsAB-Rated to Lamictal® Chewable Dispersible Tablets

68382-0108-01 5mg 100 24 Round; White to Off-White; Bisect, Z 13

68382-0109-01 25mg 100 24 Round; White to Off-White; Z 12

Lamotrigine TabletsAB-Rated to Lamictal® Tablets

68382-0006-01 25mg 100 24 Round; White to Off-White; Bisect, ZC 79

68382-0006-10 25mg 1000 12 Round; White to Off-White; Bisect, ZC 79

68382-0008-01 100mg 100 24 Round; White to Off-White; Bisect, ZC 80

68382-0008-10 100mg 1000 12 Round; White to Off-White; Bisect, ZC 80

68382-000914 150mg 60 24 Round; White to Off-White; Bisect, ZC 81

68382-0009-05 150mg 500 12 Round; White to Off-White; Bisect, ZC 81

68382-0010-14 200mg 60 24 Round; White to Off-White; Bisect, ZC 82

68382-0010-05 200mg 500 12 Round; White to Off-White; Bisect, ZC 82

Lansoprazole Delayed-Release Capsules, USP AB-Rated to Prevacid® Delayed-Release Capsules

68382-0543-06 15mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-50/15mg

68382-0543-10 15mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-50/15mg

68382-0544-06 30mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-16 30mg 90 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-01 30mg 100 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-10 30mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

Page 8: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

7 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Levofl oxacin TabletsAB-Rated to Levaquin® Tablets

68382-0015-18 250mg 50 24 Modifi ed Capsule; White to Off-White; ZC55

68382-0015-01 250mg 100 24 Modifi ed Capsule; White to Off-White; ZC55

68382-0016-18 500mg 50 24 Modifi ed Capsule; White to Off-White; ZC56

68382-0016-01 500mg 100 24 Modifi ed Capsule; White to Off-White; ZC56

68382-001718 750mg 50 24 Modifi ed Capsule; White to Off-White; ZC57

68382-0017-01 750mg 100 24 Modifi ed Capsule; White to Off-White; ZC57

Losartan Potassium Tablets, USPAB-Rated to Cozaar® Tablets

68382-0135-06 25mg 30 24 Capsule; White to Off-White; Z/2

68382-0135-16 25mg 90 24 Capsule; White to Off-White; Z/2

68382-0135-10 25mg 1000 12 Capsule; White to Off-White; Z/2

68382-0136-06 50mg 30 24 Capsule; White to Off-White; Z16/Breakline

68382-0136-16 50mg 90 24 Capsule; White to Off-White; Z16/Breakline

68382-0136-10 50mg 1000 12 Capsule; White to Off-White; Z16/Breakline

68382-0137-06 100mg 30 24 Capsule; White to Off-White; Z18

68382-0137-16 100mg 90 24 Capsule; White to Off-White; Z18

68382-0137-10 100mg 1000 12 Capsule; White to Off-White; Z18

Meloxicam Tablets, USPAB-Rated to Mobic® Tablets

68382-0050-01 7.5mg 100 24 Round; Yellow; ZC 25

68382-0050-05 7.5mg 500 12 Round; Yellow; ZC 25

68382-0051-01 15mg 100 24 Round; Yellow; ZC 26

68382-0051-05 15mg 500 12 Round; Yellow; ZC 26

Metformin HCl Tablets, USPAB-Rated to Glucophage® Tablets

68382-0028-01* 500mg 100 24 Round; White to Off-White; 70/Z

68382-0758-05 500mg 500 12 Round; White to Off-White; 70/Z

68382-0758-10 500mg 1000 12 Round; White to Off-White; 70/Z

68382-0029-01* 850mg 100 24 Oval; White to Off-White; 69/Z

68382-0759-05 850mg 500 12 Oval; White to Off-White; 69/Z

68382-0759-10 850mg 1000 12 Oval; White to Off-White; 69/Z

68382-0760-01 1000mg 100 24 Oval; White to Off-White; Bisect, Z 71

68382-0760-05 1000mg 500 12 Oval; White to Off-White; Bisect, Z 71

68382-0760-10 1000mg 1000 12 Oval; White to Off-White; Bisect, Z 71

*Scheduled NDC change in 2015

Page 9: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

8 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Morphine Sulfate Extended-Release TabletAB-Rated to MS Contin® Extended-Release Tablets

68382-0903-01 15mg 100 24 Oval; Green; N/15

68382-0904-01 30mg 100 24 Oval; Pink; N/30

68382-0905-01 60mg 100 24 Oval; White; N/60

68382-0906-01 100mg 100 24 Oval; Gray; N/100

68382-0907-01 200mg 100 24 Oval; Brown; N/200

Niacin Extended-Release TabletsSame as Niaspan® Extended-Release Tablets

68382-0201-16 500mg 90 24 Capsule-shaped; Medium-Orange; “a” logo 500

68382-0202-16 750mg 90 24 Capsule-shaped; Medium-Orange; “a” logo 750

68382-0203-16 1000mg 90 24 Oval; Medium-Orange; “a” logo 1000

Omeprazole Delayed-Release Capsules, USPAB-Rated to Prilosec® Capsules

68382-0411-06 10mg 30 24 Capsule; Amethyst Purple/White; ZA-09/10 mg

68382-0411-01 10mg 100 24 Capsule; Amethyst Purple/White; ZA-09/10 mg

68382-0412-06 20mg 30 24 Capsule; Tan/White; ZA-10/20 mg

68382-0412-01 20mg 100 24 Capsule; Tan/White; ZA-10/20 mg

68382-0412-05 20mg 500 12 Capsule; Tan/White; ZA-10/20 mg

68382-0412-10 20mg 1000 12 Capsule; Tan/White; ZA-10/20 mg

68382-0500-06 40mg 30 24 Capsule; Amethyst Purple/White; ZA-11/40 mg

68382-0500-01 40mg 100 24 Capsule; Amethyst Purple/White; ZA-11/40 mg

68382-0500-10 40mg 1000 12 Capsule; Amethyst Purple/White; ZA-11/40 mg

Oxycodone HCl Tablets, USPAB-Rated to Roxicodone® Tablets

68382-0793-01 5mg 100 12 Round; Orange; NP, Partial Bisect/11

68382-0794-01 10mg 100 12 Round; Pink; NP, Partial Bisect/12

68382-0795-01 15mg 100 12 Round; Yellow; NP, Partial Bisect/13

68382-0796-01 20mg 100 12 Round; Gray; NP, Partial Bisect/14

68382-0797-01 30mg 100 12 Round; White; NP, Partial Bisect/15

Page 10: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

9 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Paricalcitol CapsulesSame as Zemplar® Capsules

68382-0266-06 1mcg 30 48 Capsule; Gray; “a” logo ZA

68382-0267-06 2mcg 30 48 Capsule; Orange-Brown; “a” logo ZF

Paroxetine Tablets, USPSame as Paxil® Tablets

68382-0097-06 10mg 30 24 Round; White to Off-White; Bisect, ZC 15

68382-0097-16 10mg 90 24 Round; White to Off-White; Bisect, ZC 15

68382-0097-05 10mg 500 12 Round; White to Off-White; Bisect, ZC 15

68382-0097-10 10mg 1000 12 Round; White to Off-White; Bisect, ZC 15

68382-0098-06 20mg 30 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-16 20mg 90 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-01 20mg 100 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-05 20mg 500 12 Round; White to Off-White; Bisect, ZC 16

68382-0098-10 20mg 1000 12 Round; White to Off-White; Bisect, ZC 16

68382-0099-06 30mg 30 24 Round; White to Off-White; ZC17

68382-0099-16 30mg 90 24 Round; White to Off-White; ZC17

68382-0099-05 30mg 500 12 Round; White to Off-White; ZC17

68382-0099-10 30mg 1000 12 Round; White to Off-White; ZC17

68382-0001-06 40mg 30 24 Round; White to Off-White; ZC18

68382-0001-16 40mg 90 24 Round; White to Off-White; ZC18

68382-0001-05 40mg 500 12 Round; White to Off-White; ZC18

Potassium Chloride Extended-Release Capsules, USPSame as Micro-K® Extencaps® Extended-Release Capsules, USP

68382-0702-01 8mEq (600mg) 100 12 Capsule; Pale Orange; 002/002

68382-0701-01 10mEq (750mg) 100 12 Capsule; Pale Orange/Opaque White; 001/001

68382-0701-05 10mEq (750mg) 500 12 Capsule; Pale Orange/Opaque White; 001/001

Potassium Chloride Extended-Release Tablets, USPSame as K-Tab® Extended-Release Tablets

68382-0776-01 8mEq (600mg) 100 48 Round; Yellow; K-TAB

68382-0776-10 8mEq (600mg) 1000 12 Round; Yellow; K-TAB

Potassium Chloride Extended-Release Tablets, USP continued on next page

Page 11: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

10 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Potassium Chloride Extended-Release Tablets, USP (continued)Same as K-Tab® Extended-Release Tablets

68382-0600-01 10mEq (750mg) 100 48 Ovaloid; Yellow; “a”logo/K-TAB

68382-0600-10 10mEq (750mg) 1000 12 Ovaloid; Yellow; “a”logo/K-TAB

68382-0398-01 20mEq (1500mg) 100 48 Ovaloid; White; K-TAB

68382-0398-05 20mEq (1500mg) 500 12 Ovaloid; White; K-TAB

Potassium Citrate Extended-Release TabletsAB-Rated to Urocit-K® Extended-Release Tablets

68382-0536-01 5mEq 100 24 Round; Tan to Yellowish; 536

68382-0537-01 10mEq 100 24 Oval; Tan to Yellowish; 537

68382-0538-01 15mEq 100 24 Oblong; Tan to Yellowish; 538

Pramipexole Dihydrochloride TabletsAB-Rated to Mirapex® Tablets

68382-0196-16 0.125mg 90 24 Capsule; Pink; P1

68382-0196-10 0.125mg 1000 12 Capsule; Pink; P1

68382-0197-16 0.25mg 90 24 Round; Pale Blue; P2/Bisect

68382-0197-10 0.25mg 1000 12 Round; Pale Blue; P2/Bisect

68382-0198-16 0.5mg 90 24 Capsule; Lavender; P3/Bisect

68382-0198-10 0.5mg 1000 12 Capsule; Lavender; P3/Bisect

68382-0199-16 1mg 90 24 Round; Light Peach to Peach; P4/Bisect

68382-0199-10 1mg 1000 12 Round; Light Peach to Peach; P4/Bisect

68382-0200-16 1.5mg 90 24 Round; Yellow; P5/Bisect

68382-0200-10 1.5mg 1000 12 Round; Yellow; P5/Bisect

Pravastatin Sodium Tablets, USPAB-Rated to Pravachol® Tablets

68382-0070-16 10mg 90 24 Oval; White to Off-White; ZC46

68382-0070-05 10mg 500 12 Oval; White to Off-White; ZC46

68382-0071-16 20mg 90 24 Oval; White to Off-White; ZC45

68382-0071-05 20mg 500 12 Oval; White to Off-White; ZC45

68382-0072-16 40mg 90 24 Oval; White to Off-White; ZC44

68382-0072-05 40mg 500 12 Oval; White to Off-White; ZC44

68382-0073-16 80mg 90 24 Oval; White to Off-White; ZC43

68382-0073-05 80mg 500 12 Oval; White to Off-White; ZC43

Page 12: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

11 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Promethazine HCl Tablets, USPAB-Rated to Phenergan® Tablets

68382-0040-01 12.5mg 100 24 Round; White to Off-White; Bisect, ZC 01

68382-0041-01 25mg 100 24 Round; White to Off-White; Quadrisect, Z C 0 2

68382-0041-10 25mg 1000 12 Round; White to Off-White; Quadrisect, Z C 0 2

68382-0042-01 50mg 100 24 Round; White to Off-White; ZC 03

Pyridostigmine Bromide Tablets, USPAB-Rated to Mestinon® Tablets

68382-0659-01 60mg 100 24 Round; White to Off-White; Quadrisect/659

Ramipril CapsulesAB-Rated to Altace® Capsules

68382-0144-06 1.25mg 30 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg

68382-0144-01 1.25mg 100 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg

68382-0144-05 1.25mg 500 12 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg

68382-0145-06 2.5mg 30 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg

68382-0145-01 2.5mg 100 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg

68382-0145-05 2.5mg 500 12 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg

68382-0146-06 5mg 30 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg

68382-0146-01 5mg 100 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg

68382-0146-05 5mg 500 12 Capsule; White Opaque/Red Opaque; ZA-45/5 mg

68382-0147-06 10mg 30 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg

68382-0147-01 10mg 100 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg

68382-0147-05 10mg 500 12 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg

Ranitidine Injection, USPAP-Rated to Zantac® Injection

68382-0422-02 25mg/mL 2 mL 1 SD vial, 10 vials per carton

68382-0423-06 25mg/mL 6 mL 12 MD vial, single vial

Page 13: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

12 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Ribavirin CapsulesAB-Rated to Rebetol® Capsules

68382-0260-12 200mg 84 24 Capsule; White/White; ZA-12/200mg

Ribavirin TabletsAB-Rated to Copegus® Tablets

68382-0046-03 200mg 168 24 Round; Light Pink to Pink; ZC19

Risperidone Tablets, USPAB-Rated to Risperdal® Tablets

68382-0112-14 0.25mg 60 24 Round; Dark Yellow; Z/4

68382-0112-05 0.25mg 500 12 Round; Dark Yellow; Z/4

68382-0113-14 0.5mg 60 24 Round; Red-Brown; Z/6

68382-0113-05 0.5mg 500 12 Round; Red-Brown; Z/6

68382-0114-14 1mg 60 24 Round; White to Off-White; ZC75

68382-0114-05 1mg 500 12 Round; White to Off-White; ZC75

68382-0115-14 2mg 60 24 Round; Orange; ZC76

68382-0115-05 2mg 500 12 Round; Orange; ZC76

68382-0116-14 3mg 60 24 Round; Yellow; ZC77

68382-0116-05 3mg 500 12 Round; Yellow; ZC77

68382-0117-14 4mg 60 24 Round; Green; ZC78

68382-0117-05 4mg 500 12 Round; Green; ZC78

Simvastatin Tablets, USPAB-Rated to Zocor® Tablets

68382-0065-16 5mg 90 24 Oval; White; ZA19

68382-0065-10 5mg 1000 12 Oval; White; ZA19

68382-0066-16 10mg 90 24 Oval; Pink; ZA20

68382-0066-05 10mg 500 12 Oval; Pink; ZA20

68382-0066-10 10mg 1000 12 Oval; Pink; ZA20

68382-0067-16 20mg 90 24 Oval; Peach; ZA21

68382-0067-05 20mg 500 12 Oval; Peach; ZA21

68382-0067-10 20mg 1000 12 Oval; Peach; ZA21

68382-0068-16 40mg 90 24 Oval; Pink; ZA22

68382-0068-05 40mg 500 12 Oval; Pink; ZA22

68382-0068-10 40mg 1000 12 Oval; Pink; ZA22

68382-0069-16 80mg 90 24 Capsule; White to Off-White; ZA23

68382-0069-05 80mg 500 12 Capsule; White to Off-White; ZA23

68382-0069-10 80mg 1000 12 Capsule; White to Off-White; ZA23

Page 14: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

13 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Sirolimus TabletsAB-Rated to Rapamune® Tablets

68382-0520-01 0.5mg 100 24 Round; Yellow; 1

Tamsulosin HCl Capsules, USPAB-Rated to Flomax® Capsules

68382-0132-01 0.4mg 100 24 Capsule; Green/Peach; ZA-18/0.4 mg

68382-0132-10 0.4mg 1000 12 Capsule; Green/Peach; ZA-18/0.4 mg

Telmisartan TabletsAB-Rated to Micardis® Tablets

68382-0471-78 20mg 3x10 Blister Pack 36 Round; Mottled Light Brown to Mottled Brown; 471

68382-0472-78 40mg 3x10Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 472

68382-0473-78 80mg 3x10Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 473

Topiramate Capsules (Sprinkle)AB-Rated to Topamax® Sprinkle Capsules

68382-0004-14 15mg 60 24 Capsule; White Opaque/White Opaque; ZA63/15 mg

68382-0005-14 25mg 60 24 Capsule; White Opaque/White Opaque; ZA64/25 mg

Topiramate TabletsAB-Rated to Topamax® Tablets

68382-0138-14 25mg 60 24 Round; White to Off-White; ZD 16

68382-0138-05 25mg 500 12 Round; White to Off-White; ZD 16

68382-0139-14 50mg 60 24 Round; White to Off-White; ZD 15

68382-0139-05 50mg 500 12 Round; White to Off-White; ZD 15

68382-0140-14 100mg 60 24 Round; White to Off-White; ZD 14

68382-0140-05 100mg 500 12 Round; White to Off-White; ZD 14

68382-0141-14 200mg 60 24 Round; White to Off-White; ZD 13

68382-0141-05 200mg 500 12 Round; White to Off-White; ZD 13

Tramadol HCl TabletsAB-Rated to Ultram® Tablets

68382-0319-01 50mg 100 24 Round; White to Off-White; 319

68382-0319-05 50mg 500 12 Round; White to Off-White; 319

68382-0319-10 50mg 1000 12 Round; White to Off-White; 319

Page 15: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

14 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Tramadol HCl/Acetaminophen TabletsAB-Rated to Ultracet® Tablets

68382-0334-01 37.5/325mg 100 24 Capsule-shaped; White; 334

68382-0334-05 37.5/325mg 500 12 Capsule-shaped; White; 334

Venlafaxine HCl Extended-Release CapsulesAB-Rated to Effexor XR® Extended-Release Capsules

68382-0034-06 37.5mg 30 24 Capsule; Grey/White; ZA-35/37.5 mg

68382-0034-16 37.5mg 90 24 Capsule; Grey/White; ZA-35/37.5 mg

68382-0034-10 37.5mg 1000 12 Capsule; Grey/White; ZA-35/37.5 mg

68382-0035-06 75mg 30 24 Capsule; Peach/White; ZA-36/75 mg

68382-0035-16 75mg 90 24 Capsule; Peach/White; ZA-36/75 mg

68382-0035-10 75mg 1000 12 Capsule; Peach/White; ZA-36/75 mg

68382-0036-06 150mg 30 24 Capsule; Dark Orange/White; ZA-37/150 mg

68382-0036-16 150mg 90 24 Capsule; Dark Orange/White; ZA-37/150 mg

68382-0036-10 150mg 1000 12 Capsule; Dark Orange/White; ZA-37/150 mg

Venlafaxine HCl TabletsAB-Rated to Effexor® Tablets

68382-0018-01 25mg 100 24 Round; Peach; Bisect, ZC 64

68382-0019-01 37.5mg 100 24 Round; Peach; Bisect, ZC 65

68382-0020-01 50mg 100 24 Round; Peach; Bisect, ZC 66

68382-0021-01 75mg 100 24 Round; Peach; Bisect, ZC 67

68382-0101-01 100mg 100 24 Round; Peach; Bisect, ZC 68

Warfarin Sodium Tablets, USPAB-Rated to Coumadin® Tablets

68382-0052-01 1mg 100 24 Oval; Pink; Bisect, WAR 1

68382-0052-10 1mg 1000 12 Oval; Pink; Bisect, WAR 1

68382-0053-01 2mg 100 24 Oval; Lavender; Bisect, WAR 2

68382-0053-10 2mg 1000 12 Oval; Lavender; Bisect, WAR 2

68382-0064-01 2.5mg 100 24 Oval; Green; Bisect, WAR 2½

68382-0064-10 2.5mg 1000 12 Oval; Green; Bisect, WAR 2½

Warfarin Sodium Tablets, USP continued on next page

Page 16: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

15 www.zydususa.com

NDC Strength Count Case Description/Imprint Code

Warfarin Sodium Tablets, USP (continued)AB-Rated to Coumadin® Tablets

68382-0054-01 3mg 100 24 Oval; Tan; Bisect, WAR 3

68382-0054-10 3mg 1000 12 Oval; Tan; Bisect, WAR 3

68382-0055-01 4mg 100 24 Oval; Blue; Bisect, WAR 4

68382-0055-10 4mg 1000 12 Oval; Blue; Bisect, WAR 4

68382-0056-16 5mg 90 24 Oval; Peach; Bisect, WAR 5

68382-0056-01 5mg 100 24 Oval; Peach; Bisect, WAR 5

68382-0056-10 5mg 1000 12 Oval; Peach; Bisect, WAR 5

68382-0057-01 6mg 100 24 Oval; Teal; Bisect, WAR 6

68382-0058-01 7.5mg 100 24 Oval; Yellow; Bisect, WAR 7½

68382-0059-01 10mg 100 24 Oval; White; Bisect, WAR 10

Zolmitriptan Orally Disintegrating TabletsAB-Rated to Zomig-ZMT® Orally Disintegrating Tablets

68382-0715-86 2.5mg 1x6 Blister Pack 72 Round; White/mottled white to cream white; 715

68382-0717-82 5mg 1x3 Blister Pack 72 Round; White/mottled white to cream white; 717

Page 17: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

16 www.zydususa.com

Therapeutic Category Generic Name Brand

Analgesic Etodolac Extended-Release Tablets Lodine XL® Extended-Release Tablets

Analgesic Meloxicam Tablets, USP Mobic® Tablets

Analgesic Morphine Sulfate Extended-Release Tablets MS Contin® Extended-Release Tablets

Analgesic Oxycodone HCl Tablets, USP Roxicodone® Tablets

Analgesic Tramadol HCl Tablets Ultram® Tablets

Analgesic Tramadol HCl/Acetaminophen Tablets Ultracet® Tablets

Antiarrhythmic Amiodarone HCl Tablets Cordarone® Tablets

Antibiotic Clarithromycin for Oral Suspension, USP Biaxin® Granules for Oral Suspension

Antibiotic Clarithromycin Tablets, USP Biaxin® Filmtab

Antibiotic Levofl oxacin Tablets Levaquin® Tablets

Anticoagulant Warfarin Sodium Tablets, USP Coumadin® Tablets

Anticonvulsant Divalproex Sodium Capsules (Sprinkle) Depakote® Sprinkle Capsules

Anticonvulsant Divalproex Sodium Delayed-Release Tablets, USP Depakote® Delayed-Release Tablets

Anticonvulsant Divalproex Sodium Extended-Release Tablets Depakote® Extended-Release Tablets

Anticonvulsant Gabapentin Tablets Neurontin® Tablets

Anticonvulsant Lamotrigine Chewable Dispersible Tablets Lamictal® Chewable Dispersible Tablets

Anticonvulsant Lamotrigine Tablets Lamictal® Tablets

Anticonvulsant Topiramate Capsules (Sprinkle) Topamax® Sprinkle Capsules

Anticonvulsant Topiramate Tablets Topamax® Tablets

Antidepressant Bupropion Extended-Release Tablets Wellbutrin XL® Extended-Release Tablets

Antidepressant Paroxetine Tablets, USP Paxil® Tablets

Antidepressant Duloxetine HCl Delayed-Release Capsules Cymbalta® Delayed-Release Capsules

Antidepressant Venlafaxine HCl Extended-Release Capsules Effexor XR® Extended-Release Capsules

Antidepressant Venlafaxine HCl Tablets Effexor® Tablets

Antiglaucoma Agent Acetazolamide Extended-Release Capsules Diamox® Sequels

Antihyperlipidemic Fenofi brate Tablets TriCor® Tablets

Antihyperlipidemic Fenofi bric Acid Delayed-Release Capsules Trilipix® Delayed-Release Capsules

Antihyperlipidemic Pravastatin Sodium Tablets, USP Pravachol® Tablets

Antihyperlipidemic Simvastatin Tablets, USP Zocor® Tablets

Antihypertensive Ramipril Capsules Altace® Capsules

Antilipemic Niacin Extended-Release Tablets Niaspan® Extended-Release Tablets

Antimalarial Hydroxychloroquine Sulfate Tablets, USP Plaquenil® Tablets

Antimigraine Zolmitriptan Orally Disintegrating Tablets Zomig-ZMT® Orally Disintegrating Tablets

Antineoplastic Agent Anastrozole Tablets Arimidex® Tablets

Antiparkinson Agent Bromocriptine Mesylate Capsules, USP Parlodel® Capsules

Antiparkinson Agent Pramipexole Dihydrochloride Tablets Mirapex® Tablets

Antipsychotic Haloperidol Tablets, USP Haloperidol Tablets, USP

Antipsychotic Risperidone Tablets, USP Risperdal® Tablets

Antirheumatic, Cytotoxic Azathioprine Tablets, USP Imuran® Tablets

Antitussive Benzonatate Capsules, USP Tessalon® Perles

Page 18: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

17 www.zydususa.com

Therapeutic Category Generic Name Brand

Antiviral Acyclovir Tablets Zovirax® Tablets

Antiviral Ribavirin Capsules Rebetol® Capsules

Antiviral Ribavirin Tablets Copegus® Tablets

Anxiolytic Buspirone HCl Tablets, USP BuSpar® Tablets

Benign Prostatic Hypertrophy Agent Tamsulosin HCl Capsules, USP Flomax® Capsules

Cardiovascular Agent Amlodipine Besylate Tablets Norvasc® Tablets

Cardiovascular Agent Atenolol Tablets, USP Tenormin® Tablets

Cardiovascular Agent Carvedilol Tablets Coreg® Tablets

Cardiovascular Agent Isosorbide Mononitrate ER Tablets Imdur® Tablets

Cardiovascular Agent Losartan Potassium Tablets, USP Cozaar® Tablets

Central Nervous System Agent Donepezil HCl Orally Disintegrating Tablets Aricept ODT®

Cholinesterase Inhibitor Galantamine HBr Tablets, USP Razadyne® Tablets

Cholinesterase Inhibitor Pyridostigmine Bromide Tablets, USP Mestinon® Tablets

Electrolyte Supplement Potassium Chloride Extended-Release Capsules, USP Micro-K® Extencaps® Extended-Release Cap-sules, USP

Electrolyte Supplement Potassium Chloride Extended-Release Tablets, USP K-Tab® Extended-Release Tablets

Gastric Acid Secretion Inhibitor Famotidine for Oral Suspension, USP Pepcid® for Oral Suspension

Gastrointestinal Agent Lansoprazole Delayed-Release Capsules, USP Prevacid® Delayed-Release Capsules

Gastrointestinal Agent Omeprazole Delayed-Release Tablets, USP Prilosec® Capsules

Gastrointestinal Agent Promethazine HCl Tablets, USP Phenergan® Tablets

Gastrointestinal Agent Ranitidine Injection, USP Zantac® Injection

General Anesthetic Etomidate Injection, USP Amidate® Injection

Hypoglycemic Metformin HCl Tablets, USP Glucophage® Tablets

Immune Suppressant Sirolimus Tablets Rapamune® Tablets

Urinary Tract Alkalinizer Potassium Citrate Extended-Release Tablets Urocit-K® Extended-Release Tablets

Vitamin D Analog Paricalcitol Capsules Zemplar® Capsules

Page 19: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

18 www.zydususa.com

Ordering Information

Customer ServiceZydus Pharmaceuticals (USA) Inc.N114 W18850 Clinton DriveGermantown, WI 53022 Hours of Operation: 8:00 AM – 7:00 PM CST Phone: 877-ZYDUS RX, Prompt 1 (877-993-8779, Prompt 1)

Fax: 877-993-9055 Remit To1 EAB PlazaP.O. Box #10004Uniondale, NY 11555-10004 Minimum Order RequirementsThe minimum order for each SKU is one case pack (usually a quantity of 12, 24, or 48). The total order must exceed $1,000.00. All orders will be shipped on a prepaid basis utilizing the method of transportation selected by Zydus Pharmaceuticals. In cases where customer requests are expedited, more expensive, or special handling of an order, Zydus Pharmaceuticals reserves the right to charge the customer for these expenses. ReturnsPlease refer to the following page or the Zydus website, www.zydususa.com, for the current Return Goods Policy.

Page 20: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

19 www.zydususa.com

Zydus Pharmaceuticals (USA) Inc. Return Goods Policy

This return goods policy applies to all ZyGeneric (68382) and Nesher (51477) labeled pharmaceutical products. All ZyGeneric and Nesher product returns must be sent prepaid to our designated return goods processor to the following address: Inmar - South Dock, 4332 Empire Road, Fort Worth, TX 76155. Zydus does not pay fees such as processing charges for returning any product other than recalled product. For customers using other return companies for processing and destruction Zydus will not assume responsibility for charges incurred.

Request for Return Authorizations (box labels) can be made by any of the below methods:1. Accessing the Inmar website at https://clsnetlink.com (you will need to upload a PDF copy of your debit memo)2. E-mail your debit memo to [email protected]. Be sure to include NDC#, lot# and expiration dates assigned to each item.3. Fax your debit memo to Inmar at 817-868-5343

Returnable Items (For Reimbursement):• Products within six (6) months of expiration date and up to 12 months after the expiration date stated on the package.• Products must be in sealed, full, unopened, original Zydus or Nesher containers.• Products received in error or damaged in shipping to consignee (accompanied by a signed bill of lading noting such damage) if reported to Zydus customer service within 5 days of receipt and returned within 30 days.• Prior written approval is required for all return of all overstocked product with greater than 12 months expiration dating. This merchandise will be subject to a 15% restocking fee.• A DEA Form 222 is required in order to return C-II controlled substances. Please send DEA Form 222 requests to: Fax #(817) 868-5342 or E-mail: [email protected]

Returnable Items (No Credit):• Products returned without an approved Product Return Form.• Products sold on a non-returnable basis, professional sample, or free goods.• Partial or open bottles, except where required by law.• Product which has been repackaged, product purchased through a bankruptcy sale, fi re sale, distress merchandise, or product not in original container are not eligible for credit. Zydus will not credit for product damaged due to insurable causes such as fi re, fl oods or earthquake.• Products with broken seals, opened, coded, dated, damaged or missing label, or soiled packages.• Products damaged at customers warehouse or store, or not stored under proper conditions.• Products with greater than six months expiration dating or are greater than 12 months past the expiration date.• Private label products.• Return of over stocked product without prior written approval of Zydus• Merchandise distributed contrary to federal, state or local laws.• Product not purchased from either Zydus or the customer’s authorized distributor / wholesaler.

Valuation of Returns:• Direct buying customers will be issued a credit by Zydus. This credit will be issued at the lowest of either original invoice price or the prevailing contract price on the date the goods are returned to Zydus.• Non-Direct customers will receive credit directly from Inmar. If no contract exists, the credit will be issued based upon the lower of the current Zydus standard market price at the time the returned merchandise is received by Inmar OR the original Zydus contract price at point of purchase from the wholesaler.

Transportation Charges• Prepaid by customer, unless shipped in error by Zydus.• Returned product shipped collect will be refused.

Page 21: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

20 www.zydususa.com

Miscellaneous:• Representatives cannot authorize return of in date product or pick up merchandise.• Returned products will be promptly evaluated and credit will refl ect eligibility and / or ineligibility. All products returned, whether eligible for credit or not, become property of Zydus. All products are returned with the understanding that they are subject to fi nal review and evaluation by Zydus, and will be processed in accordance with the most recent return policy in effect at the time of the return.• Wholesalers are not authorized to accept returns of Zydus products except in the case of mis-shipments or other ordering errors.• Return chargebacks will be paid on original invoice date.• Zydus reserves the right to amend this policy at any time.• Claim merchandise-even exchange or credit will be allowed for loss or damage evident at delivery time if noted on the carrier’ delivery receipt and reported to us within fi ve days. Concealed loss or damage must be inspected by carrier within 15 days after delivery and carrier’s inspection report must be forwarded to Zydus USA.• Zydus USA policy strictly prohibits any sales representative or any other employee from giving samples or stock packages to any customer to replace merchandise. All returns must be made according to this return goods policy.

Revised Effective 04/15/2015

Zydus Pharmaceuticals (USA) Inc. Return Goods Policy (continued)

Page 22: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules

21 www.zydususa.com

Contact Information

Address Zydus Pharmaceuticals USA Inc. 73 Route 31 North Pennington, NJ 08534Telephone 609-730-1900Fax 609-730-1998Website www.zydususa.com

Customer Service

Telephone 877-993-8779, Prompt 1Fax 877-993-9055Email [email protected] Medical Affairs Telephone 877-993-8779, Prompt 2Fax 678-581-4401Email [email protected]

Returns Inmar 800-967-5952

Page 23: ZY1501 Catalog Jul2015 V2 - Zydus Pharmaceuticals...(updated as of August 2015) SUMMER 2015 1 NDC Strength Count Case Description/Imprint Code Acetazolamide Extended-Release Capsules